Literature DB >> 22814862

Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).

Marco Gessi1, Sally R Lambert, Libero Lauriola, Andreas Waha, V Peter Collins, Torsten Pietsch.   

Abstract

Rosette-forming glioneuronal tumors (RGNT) of the fourth ventricle are rare mixed glioneuronal tumors included in the revised WHO classification of central nervous system tumors, showing partial histological similarities to pilocytic astrocytomas. To evaluate potential similarities at the molecular level between these tumors, we analysed a series of 10 RGNT for the presence of KIAA1549-BRAF fusions using interphase fluorescence in situ hybridisation. However, we found no cases showing KIAA1549-BRAF gene fusion or BRAF (V600E) mutation. Our data support the hypothesis that RGNT may represent a distinct entity among the glioneuronal tumors of the central nervous system, with molecular features different from pilocytic astrocytomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814862     DOI: 10.1007/s11060-012-0940-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  16 in total

1.  Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.

Authors:  Genevieve Schindler; David Capper; Jochen Meyer; Wibke Janzarik; Heymut Omran; Christel Herold-Mende; Kirsten Schmieder; Pieter Wesseling; Christian Mawrin; Martin Hasselblatt; David N Louis; Andrey Korshunov; Stefan Pfister; Christian Hartmann; Werner Paulus; Guido Reifenberger; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2011-01-29       Impact factor: 17.088

2.  Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers.

Authors:  Deborah Packham; Robyn L Ward; Vita Ap Lin; Nicholas J Hawkins; Megan P Hitchins
Journal:  Diagn Mol Pathol       Date:  2009-06

3.  PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.

Authors:  Erika F Rodriguez; Bernd W Scheithauer; Caterina Giannini; Amanda Rynearson; Ling Cen; Bridget Hoesley; Heather Gilmer-Flynn; Jann N Sarkaria; Sarah Jenkins; Jin Long; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2010-11-28       Impact factor: 17.088

4.  A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor?

Authors:  Takashi Komori; Bernd W Scheithauer; Takanori Hirose
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

Review 5.  Rosette-forming glioneuronal tumour of the fourth ventricle: report of a case with clinical and surgical implications.

Authors:  A Albanese; A Mangiola; A Pompucci; G Sabatino; M Gessi; L Lauriola; C Anile
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

6.  The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group.

Authors:  Marc K Rosenblum
Journal:  Brain Pathol       Date:  2007-07       Impact factor: 6.508

7.  Dysembryoplastic neuroepithelial tumour of the cerebellum.

Authors:  K Kuchelmeister; T Demirel; E Schlörer; M Bergmann; F Gullotta
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.

Authors:  D T W Jones; S Kocialkowski; L Liu; D M Pearson; K Ichimura; V P Collins
Journal:  Oncogene       Date:  2009-04-13       Impact factor: 9.867

9.  Rosette-forming glioneuronal tumors of the posterior fossa.

Authors:  Manish N Shah; Jeffrey R Leonard; Arie Perry
Journal:  J Neurosurg Pediatr       Date:  2010-01       Impact factor: 2.375

Review 10.  Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications.

Authors:  M Karafin; G I Jallo; M Ayars; C G Eberhart; F J Rodriguez
Journal:  Clin Neuropathol       Date:  2011 Nov-Dec       Impact factor: 1.368

View more
  10 in total

1.  Molecular heterogeneity characterizes glioblastoma with lipoblast/adipocyte-like cytology.

Authors:  Marco Gessi; Gerrit H Gielen; Dorota Denkhaus; Manila Antonelli; Felice Giangaspero; Anja Zur Mühlen; Anna Sophia Japp; Torsten Pietsch
Journal:  Virchows Arch       Date:  2015-04-21       Impact factor: 4.064

Review 2.  Uncommon pediatric tumors of the posterior fossa: pathologic and molecular features.

Authors:  C Dunham
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

3.  Molecular Profiling of a Rare Rosette-Forming Glioneuronal Tumor Arising in the Spinal Cord.

Authors:  Lucas Tadeu Bidinotto; Cristovam Scapulatempo-Neto; Alan Mackay; Gisele Caravina de Almeida; Bernd Walter Scheithauer; Gustavo Noriz Berardinelli; Raul Torrieri; Carlos Afonso Clara; Leonir Terezinha Feltrin; Marta Viana-Pereira; Marileila Varella-Garcia; Chris Jones; Rui Manuel Reis
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

4.  Histopathological, molecular, clinical and radiological characterization of rosette-forming glioneuronal tumor in the central nervous system.

Authors:  Chenlong Yang; Jingyi Fang; Guang Li; Shaowu Li; Tingting Ha; Jiangfei Wang; Bao Yang; Jun Yang; Yulun Xu
Journal:  Oncotarget       Date:  2017-11-24

5.  Surgical treatment of a rare rosette-forming glioneuronal tumor in the pineal region.

Authors:  Sajjad Muhammad; Ahmad Hafez; Atte Karppinen; Mika Niemelä
Journal:  Surg Neurol Int       Date:  2020-04-18

Review 6.  Rosette-forming glioneuronal tumor: an illustrative case and a systematic review.

Authors:  Caleb P Wilson; Arpan R Chakraborty; Panayiotis E Pelargos; Helen H Shi; Camille K Milton; Sarah Sung; Tressie McCoy; Jo Elle Peterson; Chad A Glenn
Journal:  Neurooncol Adv       Date:  2020-09-09

7.  Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle: A Case of Relapse Treated with Proton Beam Therapy.

Authors:  Antonella Cacchione; Angela Mastronuzzi; Andrea Carai; Giovanna Stefania Colafati; Francesca Diomedi-Camassei; Antonio Marrazzo; Alessia Carboni; Evelina Miele; Lucia Pedace; Marco Tartaglia; Maurizio Amichetti; Francesco Fellin; Mariachiara Lodi; Sabina Vennarini
Journal:  Diagnostics (Basel)       Date:  2021-05-19

8.  Posterior fossa and spinal gangliogliomas form two distinct clinicopathologic and molecular subgroups.

Authors:  Kirti Gupta; Wilda Orisme; Julie H Harreld; Ibrahim Qaddoumi; James D Dalton; Chandanamali Punchihewa; Racquel Collins-Underwood; Thomas Robertson; Ruth G Tatevossian; David W Ellison
Journal:  Acta Neuropathol Commun       Date:  2014-02-14       Impact factor: 7.801

9.  Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.

Authors:  Frank Y Lin; Katie Bergstrom; Richard Person; Abhishek Bavle; Leomar Y Ballester; Sarah Scollon; Robin Raesz-Martinez; Andrew Jea; Sherri Birchansky; David A Wheeler; Stacey L Berg; Murali M Chintagumpala; Adekunle M Adesina; Christine Eng; Angshumoy Roy; Sharon E Plon; D Williams Parsons
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-09

10.  Rosette-forming Glioneuronal Tumor: A Rare Posterior Fossa Tumor in an Adolescent.

Authors:  Goutam Bera; Amitabha Das; Sandip Chatterjee; Uttara Chatterjee
Journal:  J Pediatr Neurosci       Date:  2017 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.